Education
About Us
Working with TipRanks
Follow Us
Fairmount Funds Management LLC Insider Profile
11 Followers
Fairmount Funds Management LLC, Director at Cogent Biosciences, holds 9.00M shares in Cogent Biosciences (Ticker: COGT), holds 3.46M shares in Viridian Therapeutics (Ticker: VRDN), holds 3.37M shares in Oruka Therapeutics (Ticker: ORKA). Most recently, Fairmount Funds Management LLC Bought ― shares of Cogent Biosciences on Jul 14, 2025 for an estimated value of $25.00M.
Fairmount Funds Management LLC Cogent Biosciences (COGT)Director
Cogent Biosciences (COGT)
Director
Ranked #2,634 out of 102,971 Corporate Insiders
Profitable Transactions
7 out of 13 Profitable Transactions
Average Return
+43.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Fairmount Funds Management LLC's holdings
Insider Roles
Roles that Fairmount Funds Management LLC holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 17, 2023 - Jul 17, 2024
Return:+136.50%
The most profitable trade made by Fairmount Funds Management LLC
Fairmount Funds Management LLC's Trading History
Cogent Biosciences
Jul 14, 2025
Director
Informative Buy
25.00M
$107.05M
Viridian Therapeutics
Jun 11, 2025
Director, Ten Percent Owner
Uninformative Buy
166.35K
$64.15M
Apogee Therapeutics
Apr 01, 2024
Director
Uninformative Buy
―
$80.21M
Dianthus Therapeutics
Oct 01, 2024
Director
Uninformative Sell
―
$56.01M
Spyre Therapeutics
Apr 25, 2024
Director
Uninformative Buy
118.18M
$81.87M
Oruka Therapeutics
Nov 21, 2024
Director, Ten Percent Owner
Uninformative Buy
3.57M
$51.83M
Zenas BioPharma, Inc.
Sep 16, 2024
Director
Uninformative Buy
―
$26.99M
Jade Biosciences
―
Director, Ten Percent Owner
―
―
Crescent Biopharma
―
Director, Ten Percent Owner
―
―
List of latest transactions for each holding click on a transaction to see Fairmount Funds Management LLC's performance on stock
You May Also Like
Fairmount Funds Management LLC insider profile FAQ
What is the percentage of profitable transactions made by Fairmount Funds Management LLC?
The percentage of profitable transactions made by Fairmount Funds Management LLC is 54%.
What is the average return per transaction made by Fairmount Funds Management LLC?
The average return per transaction made by Fairmount Funds Management LLC is 43.90%.
What stocks does Fairmount Funds Management LLC hold?
Fairmount Funds Management LLC holds: COGT, VRDN, APGE, DNTH, SYRE, ORKA, ZBIO, JBIO, CBIO stocks.
What was Fairmount Funds Management LLC’s latest transaction?
Fairmount Funds Management LLC latest transaction was an Informative Buy of $25.00M.
What was Fairmount Funds Management LLC's most profitable transaction?
Fairmount Funds Management LLC’s most profitable transaction was an Informative Buy of APGE stock on July 17, 2023. The return on the trade was 136.50%.
What is Fairmount Funds Management LLC's role in Cogent Biosciences?
Fairmount Funds Management LLC's role in Cogent Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.